Emerging Therapies for Genetic Deafness: The Rise of Precision Gene Editing

Hearing loss is a prevalent sensory disorder with profound social and health impacts. Although hearing aids and cochlear implants can significantly restore auditory perception, they do not address the underlying genetic causes. Inherited forms of hearing loss, often monogenic, are ideal candidates for gene therapy, particularly since over 150 genes have been linked to deafness....

Continue reading at PubMed

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

No actionable change — gene-editing therapies for genetic deafness remain in early-stage research and are not yet available in clinical practice; audiologists should monitor the pipeline but need not alter current protocols.

✦ Why It Matters ✦

Precision gene editing represents a potential paradigm shift from managing genetic deafness with devices to actually correcting its underlying cause, which could fundamentally reshape the audiology care model.

✦ Key Points ✦

01Review contrasts precision gene-editing therapies with hearing aids and cochlear implants as current standards of care.
02Gene-editing tools (e.g., CRISPR-based approaches) are being explored as curative strategies for inherited hearing loss.
03Current device-based interventions address symptoms; gene therapies aim to correct the underlying genetic defect.
04Multiple gene targets associated with hereditary deafness are under investigation.
05Clinical translation remains in early stages, with trials limited and long-term outcomes unknown.

✦ Claims & Evidence ✦

ClaimEvidenceSupport

Precision gene-editing therapies represent an emerging alternative to hearing aids and cochlear implants for genetic deafness.

studypartially supported

Hearing aids and cochlear implants are the current standards of care for genetic deafness.

guidelinesupported

✦ Research metadata ✦

PMID: 42868209
DOI: 10.1097/AUD.0000000000001903.
Journal: Ear and Hearing
Publication type: review
Evidence level: 5
Population: Literature review; no direct human study population
Intervention: Precision gene-editing therapies (e.g., CRISPR-based) for genetic deafness
Comparator: Hearing aids and cochlear implants

Primary outcomes

Comparative efficacy of gene-editing vs. device-based interventions for genetic deafness; Stage of clinical translation for leading gene-editing approaches

✦ Related stories ✦

PubMed·Journal article·Research (general)·3mo ago

Impaired speech-in-noise perception in individuals with a history of hearing symptoms after noise exposure

Audiologists should consider supplementing standard audiograms with speech-in-noise testing for patients reporting noise-exposure symptoms, as normal thresholds alone may miss clinically meaningful hearing dysfunction consistent with cochlear synaptopathy (hidden hearing loss).

PubMed·Journal article·Research (general)·4mo ago

Effects of Hearing Intervention on Cognitive Function in Patients with Presbycusis: A Systematic Review and Meta-Analysis

This systematic review and meta-analysis provides the strongest available evidence that hearing intervention positively impacts cognitive function in older adults with age-related hearing loss; audiologists should use these findings to counsel patients and reinforce the...

PubMed·Journal article·Research (general)·4mo ago

The Genetic Causes of Auditory Neuropathy: A Systematic Review

Genetic testing for auditory neuropathy is clinically meaningful because the causative gene can influence cochlear implant candidacy and expected outcomes; audiologists should advocate for genetic workup in confirmed auditory neuropathy cases.

PubMed·Journal article·Research (general)·3mo ago

Hearing Loss in Adults With Diabetes and Prediabetes: A Systematic Review and Meta-Analysis

Audiologists should consider routine hearing screening for adult patients with known diabetes or prediabetes, as this meta-analysis provides strong epidemiological evidence linking both conditions to increased prevalence and severity of hearing loss.

PubMed·Journal article·Research (general)·3w ago

Increased listening effort and decreased speech perception at high presentation sound levels in older hearing-impaired adult listeners

Audiologists should avoid assuming that higher presentation levels always benefit older hearing-impaired listeners; fitting and counselling protocols should account for the paradoxical degradation in speech perception and increased listening effort at high levels.

PubMed·Clinical trial·Research (general)·4w ago

Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial

are secondary and exploratory — audiologists should not change practice based on these biomarker findings alone, but the study adds biological plausibility to hearing intervention as a potential tool for brain health preservation.

PubMed·Preprint·Research (general)·3mo ago

Older adults show overexaggerated and larger noise-related degradation in their neural tracking of speech

This finding suggests age-related declines in how the brain tracks speech in noise go beyond peripheral hearing loss; audiologists should be cautious attributing all speech-in-noise difficulty in older adults to the audiogram alone, though the preprint has not yet been...

PubMed·Journal article·Research (general)·3w ago

Incidence and characteristics of teprotumumab-associated ototoxicity in thyroid eye disease: A systematic review and meta-analysis

Audiologists and ENTs should be aware that teprotumumab carries a quantifiable ototoxicity risk; patients receiving this drug for thyroid eye disease warrant hearing monitoring, and audiologists may be asked to provide baseline and follow-up audiometric testing.